Search

everythinglearnresearchcommunity

for

Search:↓

Rice bran extract caused moderate skin irritation but no eye irritation, while a diluted essence was not irritating to skin and only slightly to guinea pigs.

A new pain-measuring system using sensors and AI can effectively detect pain in mice, which may help assess pain in humans and develop treatments.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Analog 23 is a promising compound for prostate cancer treatment.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Spin traps like PBN could protect skin from pollution and sunlight in cosmetics but need more research for safe use.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Some common medications can lower PSA levels in 45-year-old German men.

Centipeda minima and brevilin A protect skin cells from damage and aging.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

The solid microneedle booster improves hair regrowth and follicle enrichment when used with minoxidil.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Increased energy use in Pik3r1-related insulin resistance isn't due to Ucp1 thermogenesis.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.